Basic Information
| LncRNA/CircRNA Name | XLOC_012255 |
| Synonyms | lnc-PCTP-2, XLOC_012255, linc-PCTP |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR etc. |
| Sample | lung adenocarcinoma tissues |
| Expression Pattern | down-regulated |
| Function Description | We initially identified a number of interesting candidate lncRNAs for further analysis. Of these, LOC100132354 and RPLP0P2 exhibited the most significantly changed expression in our analysis of 100 pairs of lung adenocarcinoma and normal lung tissue samples. The expression of LOC100132354 was significantly higher in lung adenocarcinoma than in the adjacent tissues, while the expression of RPLP0P2 was significantly lower in lung adenocarcinoma than in the adjacent tissues. |
| Pubmed ID | 25089627 |
| Year | 2014 |
| Title | Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. |
External Links
| Links for XLOC_012255 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |